JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 4, 2006; DOI: 10.1124/jpet.105.097923

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.097923v1
317/1/139    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Roland Seifert
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xie, S.-X.
Right arrow Articles by Seifert, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xie, S.-X.
Right arrow Articles by Seifert, R.


Received for publication November 2, 2005.
Revised December 23, 2005.
Accepted for publication January 3, 2006.

Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated imidazolylpropylguanidines

Sheng-Xue Xie 1, Prasanta Ghorai 2, Qi-Zhuang Ye 1, Armin Buschauer 2, Roland Seifert 2*

1 University of Kansas 2 University of Regensburg

* Address correspondence to: E-mail: roland.seifert{at}chemie.uni-regensburg.de

Abstract

Impromidine (IMP) and arpromidine (ARP)-derived guanidines are more potent and efficacious guinea pig (gp) histamine H2-receptor (gpH2R)- than human (h) H2R agonists and histamine H1-receptor (H1R) antagonists with preference for hH1R relative to gpH1R. We examined NG-acylated imidazolylpropylguanidines (AIPGs) which are less basic than guanidines at hH2R, gpH2R, rat H2R (rH2R), hH1R and gpH1R expressed in Sf9 cells as probes for ligand-specific receptor conformations. AIPGs were similarly potent H2R agonists as the corresponding guanidines IMP and ARP, respectively. Exchange of pyridyl in ARP against phenyl increased AIPG potency ten-fold, yielding the most potent agonists at the hH2R-Gs{alpha} fusion protein and gpH2R-Gs{alpha} identified so far. Some AIPGs were similarly potent and efficacious at hH2R-Gs{alpha} and gpH2R-Gs{alpha}. AIPGs stabilized the ternary complex in hH2R-Gs{alpha} and gpH2R-Gs{alpha} differently than the corresponding guanidines. Guanidines, AIPGs and small H2R agonists exhibited distinct agonist properties at hH2R, gpH2R and rH2R measuring adenylyl cyclase activity. In contrast to ARP and IMP, AIPGs were partial H1R agonists exhibiting higher efficacies at hH1R than at gpH1R. This is remarkable since so far, all bulky H1R agonists exhibited higher efficacies at gpH1R than at hH1R. Collectively, our data suggest that AIPGs stabilize different active conformations in hH2R, gpH2R and rH2R than guanidines and that in contrast to guanidines, AIPGs are capable of stabilizing a partially active state of hH1R.


Key words: GPCR species isoforms, Guanidines, Histamine H1-receptor, Histamine H2-receptor, NG-acylated imidazolylpropylguanidines, Sf9 insect cells


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
H. Preuss, P. Ghorai, A. Kraus, S. Dove, A. Buschauer, and R. Seifert
Constitutive Activity and Ligand Selectivity of Human, Guinea Pig, Rat, and Canine Histamine H2 Receptors
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 983 - 995.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. Preuss, P. Ghorai, A. Kraus, S. Dove, A. Buschauer, and R. Seifert
Mutations of Cys-17 and Ala-271 in the Human Histamine H2 Receptor Determine the Species Selectivity of Guanidine-Type Agonists and Increase Constitutive Activity
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 975 - 982.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S.-X. Xie, A. Kraus, P. Ghorai, Q.-Z. Ye, S. Elz, A. Buschauer, and R. Seifert
N1-(3-Cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a Potent Partial Agonist for the Human Histamine H1- and H2-Receptors
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1262 - 1268.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.